-
DE
ADMA (Asymmetric Dimethylarginine) is an endogenous compound that inhibits nitric oxide production and serves as a biomarker for cardiovascular disease risk.
ADMA (Asymmetric Dimethylarginine) is an endogenous compound that inhibits nitric oxide production and serves as a biomarker for cardiovascular disease risk.
ADMA (Asymmetric Dimethylarginine) is a naturally occurring amino acid derivative produced in the human body during protein metabolism. It circulates in the bloodstream and is widely recognized as an important biomarker for vascular health and cardiovascular disease risk.
ADMA inhibits the enzyme eNOS (endothelial nitric oxide synthase), which is responsible for producing nitric oxide (NO). Nitric oxide plays a central role in relaxing blood vessel walls, regulating blood pressure, and protecting against atherosclerosis. Elevated ADMA levels lead to reduced NO availability, a condition known as endothelial dysfunction – an early indicator of vascular damage.
Several conditions and lifestyle factors can increase ADMA concentrations in the blood:
Elevated ADMA levels are associated with a higher risk of heart attack, stroke, and other cardiovascular events. Research shows that ADMA is an independent risk factor for mortality in patients with chronic kidney failure and heart disease. ADMA has also been linked to the development of pulmonary hypertension and preeclampsia (high blood pressure during pregnancy).
ADMA is measured from a blood sample, typically using high-performance liquid chromatography (HPLC) or immunological assays (ELISA). Normal plasma values typically range between 0.4 and 0.9 µmol/L. Values above this range may indicate an elevated cardiovascular risk. ADMA measurement is primarily used in research settings and specialized cardiovascular diagnostic centers.
No standardized drug therapy specifically targeting ADMA reduction has been established to date. However, several interventions have shown a positive effect on ADMA levels:
ADMA is a significant endogenous inhibitor of nitric oxide synthesis and an established biomarker for endothelial dysfunction and cardiovascular risk. Measuring ADMA levels enables early assessment of vascular health status and can contribute to optimizing preventive strategies in at-risk patients.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.